Wilbanks Smith & Thomas Asset Management LLC Acquires 654 Shares of Zimmer Biomet Holdings, Inc. (ZBH)

Wilbanks Smith & Thomas Asset Management LLC increased its holdings in shares of Zimmer Biomet Holdings, Inc. (NYSE:ZBH) by 3.1% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 21,956 shares of the medical equipment provider’s stock after buying an additional 654 shares during the period. Wilbanks Smith & Thomas Asset Management LLC’s holdings in Zimmer Biomet Holdings were worth $2,819,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also made changes to their positions in the stock. Enterprise Financial Services Corp increased its stake in Zimmer Biomet Holdings by 0.3% during the 2nd quarter. Enterprise Financial Services Corp now owns 2,646 shares of the medical equipment provider’s stock worth $340,000 after buying an additional 9 shares during the period. Sandy Spring Bank increased its stake in Zimmer Biomet Holdings by 1.7% during the 1st quarter. Sandy Spring Bank now owns 1,222 shares of the medical equipment provider’s stock worth $149,000 after buying an additional 20 shares during the period. Cleararc Capital Inc. grew its holdings in Zimmer Biomet Holdings by 0.5% during the 1st quarter. Cleararc Capital Inc. now owns 4,897 shares of the medical equipment provider’s stock worth $598,000 after acquiring an additional 25 shares in the last quarter. Parkside Financial Bank & Trust grew its holdings in Zimmer Biomet Holdings by 3.9% during the 2nd quarter. Parkside Financial Bank & Trust now owns 872 shares of the medical equipment provider’s stock worth $112,000 after acquiring an additional 33 shares in the last quarter. Finally, CWA Asset Management Group LLC grew its holdings in Zimmer Biomet Holdings by 1.8% during the 2nd quarter. CWA Asset Management Group LLC now owns 1,952 shares of the medical equipment provider’s stock worth $251,000 after acquiring an additional 34 shares in the last quarter. 85.36% of the stock is currently owned by hedge funds and other institutional investors.

TRADEMARK VIOLATION NOTICE: This piece was reported by Community Financial News and is the property of of Community Financial News. If you are accessing this piece on another site, it was illegally stolen and reposted in violation of U.S. and international copyright law. The legal version of this piece can be read at https://www.com-unik.info/2017/10/10/wilbanks-smith-thomas-asset-management-llc-acquires-654-shares-of-zimmer-biomet-holdings-inc-zbh.html.

Shares of Zimmer Biomet Holdings, Inc. (ZBH) traded up 0.47% during mid-day trading on Tuesday, reaching $118.07. 349,877 shares of the company were exchanged. Zimmer Biomet Holdings, Inc. has a 12 month low of $95.63 and a 12 month high of $133.49. The firm has a market capitalization of $23.87 billion, a price-to-earnings ratio of 33.63 and a beta of 1.19. The company’s 50-day moving average is $115.26 and its 200 day moving average is $120.42.

Zimmer Biomet Holdings (NYSE:ZBH) last released its quarterly earnings data on Thursday, July 27th. The medical equipment provider reported $2.08 EPS for the quarter, missing analysts’ consensus estimates of $2.10 by ($0.02). The business had revenue of $1.95 billion during the quarter, compared to analyst estimates of $1.95 billion. Zimmer Biomet Holdings had a return on equity of 16.70% and a net margin of 9.12%. The business’s revenue for the quarter was up 1.1% compared to the same quarter last year. During the same period in the prior year, the firm earned $2.02 EPS. Analysts predict that Zimmer Biomet Holdings, Inc. will post $8.23 EPS for the current year.

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, October 27th. Shareholders of record on Friday, September 22nd will be issued a $0.24 dividend. This represents a $0.96 dividend on an annualized basis and a yield of 0.82%. The ex-dividend date of this dividend is Thursday, September 21st. Zimmer Biomet Holdings’s dividend payout ratio is presently 27.59%.

In other Zimmer Biomet Holdings news, VP Tony W. Collins sold 16,986 shares of Zimmer Biomet Holdings stock in a transaction on Monday, July 31st. The shares were sold at an average price of $121.74, for a total value of $2,067,875.64. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Insiders own 1.07% of the company’s stock.

Several research firms have commented on ZBH. Morgan Stanley boosted their price target on shares of Zimmer Biomet Holdings from $137.00 to $150.00 and gave the stock an “overweight” rating in a report on Monday, July 17th. Piper Jaffray Companies reiterated a “buy” rating and set a $141.00 price target on shares of Zimmer Biomet Holdings in a report on Friday, July 14th. Stifel Nicolaus reiterated a “hold” rating and set a $125.00 price target on shares of Zimmer Biomet Holdings in a report on Friday, July 14th. Bank of America Corporation reiterated a “buy” rating and set a $158.00 price target on shares of Zimmer Biomet Holdings in a report on Friday, July 14th. Finally, Royal Bank Of Canada reiterated an “outperform” rating and set a $140.00 price target on shares of Zimmer Biomet Holdings in a report on Friday, July 14th. Three research analysts have rated the stock with a sell rating, eight have assigned a hold rating, thirteen have given a buy rating and one has given a strong buy rating to the company. Zimmer Biomet Holdings has an average rating of “Hold” and a consensus price target of $136.55.

About Zimmer Biomet Holdings

Zimmer Biomet Holdings, Inc is engaged in designing, manufacturing and marketing of orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; office-based technologies; spine, craniomaxillofacial and thoracic products; dental implants, and related surgical products.

Want to see what other hedge funds are holding ZBH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Zimmer Biomet Holdings, Inc. (NYSE:ZBH).

Institutional Ownership by Quarter for Zimmer Biomet Holdings (NYSE:ZBH)

What are top analysts saying about Zimmer Biomet Holdings Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Zimmer Biomet Holdings Inc. and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit